PRZOOM - /newswire/ -
Point Roberts, WA, United States, 2005/11/04 - Threat of Avian Flu Pandemic Escalates Need for Biological Countermeasures. BiodefenseStocks.com, and HomelandDefenseStocks.com, report on the growth of the biodefense arena in light of the challenges & opportunities realized thru Project BioShield..
BiodefenseStocks.com (BDS), and HomelandDefenseStocks.com (HDS), investor news portals for the Biodefense and Homeland Security sectors, report on the growth of the biodefense arena in light of the challenges and opportunities realized through Project BioShield. Punk, Ziegel & Company’s Senior Biotechnology Analyst, Sharon Seiler provides perspective on the current environment under BioShield, while Hollis-Eden Pharmaceuticals, Inc. (NASDQ: HEPH), VaxGen Inc. (OTC.PK: VXGN), Aethlon Medical, Inc. (OTCBB: AEMD) and Acambis plc (LSE: ACM) reveal industry insights.
Report : Project BioShield – Challenging and Strengthening the Biodefense Arena
The BDS and HDS Websites do not make recommendations, but offer unique information portals for investors to explore news, articles, and recent research.
Featured Company: (BDS and HDS are compensated as disclosed in disclaimer)
Aethlon Medical, Inc (OTCBB: AEMD) is pioneering the development of therapeutic devices that mimic the immune response of clearing viruses and viral toxins from circulation. The Company’s lead product, the HemopurifierTM, converges the established principals of hemodialysis and affinity chromatography with the discovery of compounds that effectively adhere to the surface of a multiple envelope viruses. The HemopurifierTM is targeted to treat acute and chronic infectious diseases, including, drug and vaccine resistant Biological Weapons, the Human Immunodeficiency Virus (HIV), and the Hepatitis-C Virus (HCV). The Company has an experienced management team, which receives support and guidance from globally recognized science and regulatory advisors representing the infectious disease, biowarfare, and dialysis industries.
Member: US National Defense Industries Association (NDIA), Canadian Defence Industries Association (CDIA)
Investor Incite Newsletter
InvestorIdeas.com’s free "Investor Incite" Newsletter consists of company and industry updates, investment research and developing trends in key areas such as Homeland Security, Renewable Energy, Oil and Gas and more.
Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. The site is currently compensated for by its "featured companies." Aethlon Medical, Inc. (OTCBB: AEMD) Three thousand dollars per month, plus restricted shares equivalent to five thousand dollars per month.